Navigation Links
Tosedostat OPAL Study Final Results Selected for Oral Presentation at the 2011 American Society of Hematology (ASH) Annual Meeting
Date:12/6/2011

rather than intercalation with DNA -- pixantrone alkylates DNA -- forming stable DNA adducts with particular specificity for CpG-rich, hyper-methylated sites. These structural differences resulted in significantly enhanced anti-lymphoma activity compared to doxorubicin in preclinical models. In addition, the structural motifs on anthracycline-like agents that are responsible for the generation of oxygen free radicals and the formation of toxic drug-metal complexes have also been modified in pixantrone in an effort to prevent the binding of iron and perpetuation of superoxide production -- both of which are the putative mechanism for anthracycline induced acute cardiotoxicity. These novel pharmacologic differences may allow re-introduction of anthracycline-like potency in the treatment of relapsed/refractory diffuse large lymphoma without unacceptable rates of cardiotoxicity.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of pixantrone and tosedostat include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with pixantrone and tosedostat in particular including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of NHL and/or other tumors as determined by the U.S. Food and Drug Administration (the "FDA") and/or the European Medicines Agency (th
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmathene Announces Publication of Phase I Study Results for Anthrax Anti-toxin Valortim®
2. Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes
3. New Study Shows AFECTAIR® Significantly Improved Delivery of Nitric Oxide Under Simulated Neonatal Ventilatory Conditions
4. First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease
5. New Gene Study of ADHD Points to Defects in Brain Signaling Pathways
6. RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure
7. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
8. Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinsons Disease
9. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
10. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
11. New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, Ltd. ... Patent and Trademark Office (USPTO) has issued a ... dendritic cell-based immunotherapeutic vaccine targeting six tumor antigens ... of US Patent No. 8,871,211, which issued October ... by administering a dendritic cell composition comprising peptide ...
(Date:12/17/2014)... and RALEIGH, N.C. , Dec. ... LLC (CTMC), and Integrated Clinical Trial Services, LLC ... retention for clinical trials announce that they have ... Marketing Services (i-CTMS). i-CTMS will provide a broad ... pharmaceutical, biotechnology and medical device companies. ...
(Date:12/15/2014)... , Dec. 12, 2014 Research and ... the addition of the "MEMS Gyroscopes Analog ... Analysis" report to their offering. ... gyroscopes for tactical grade applications made a lot ... term of reliability. They are now accepted in ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... ANF Group, Inc ., a South Florida based ... 170,000-square-foot Joe DiMaggio Children,s Hospital – the first free ... (Photo: http://photos.prnewswire.com/prnh/20110614/FL18288 ) The hospital,s ... designed to earn Gold Leadership in Energy and Environment ...
... June 14, 2011 CVS/pharmacy provides ... at more than 7,200 convenient locations nationwide. Shoppers have come ... larger-than-ever selection of gifts, goods and everyday needs. From popular ... the hottest gear and thoughtful keepsakes perfect for every dad, ...
Cached Medicine Technology:ANF Group, Inc. Completes New Joe DiMaggio Children's Hospital 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 2Find the Best in Gadgets, Grilling and Grooming in Just One Stop This Father's Day at CVS/pharmacy 3
(Date:12/21/2014)... December 21, 2014 Theme ... a new intro plugin for Final Cut Pro X ... videos, logos, and more with absolute ease.” Said Christiana ... users the tools needed to easily animate their media ... Cut Pro X users to animate pictures, videos, logos, ...
(Date:12/21/2014)... 21, 2014 Concept Plus, LLC. a ... headquartered in Fairfax, VA., today announced it has been ... 50 list, which ranks the fastest growing government contracting small ... to 2013. , This is the first year that Concept ... # 20 with a 95.92% compound annual growth rate. “For ...
(Date:12/20/2014)... has recently announced its new collection of sweet 16 ... dresses for the coming new year. , Weddingshe.com ... global women. Now, all the models on its website ... Among the new items, the model of 10986064 (Fresh ... popular. What’s more, Weddingshe.com also provides a fast and ...
(Date:12/20/2014)... The print component of Healthy Aging is distributed ... 160,000 copies and an estimated readership of 420,000. The ... media strategy and across a network of top news ... of the campaign, click here . , The ... of CTV’s The Social. Lainey Lui, Melissa Grelo, ...
(Date:12/20/2014)... the distinguished wedding dress manufacturer and retailer, has just ... has recently updated its official blog with the latest ... Angeldress Blog has recommended some new designs and ... in offering a huge selection of elegant products and ... are very carefully selected based on the design and ...
Breaking Medicine News(10 mins):Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Tons of New-in Winter Sweet 16 Dresses from Weddingshe Online Now 2Health News:The ladies of The Social urge Canadian women to put themselves first over the holiday season and into the new year in Mediaplanet’s “Women’s Health” campaign 2Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2
... 16 Caring for children with,autism is wreaking havoc ... and security, according to a new study, Living with,Autism, ... Insurance,Company (MassMutual). , ... so severe for families,living with autism -- the numbers ...
... The Paul "Bear" Bryant Awards committee of the ... the Year finalists. The winner will be voted on by ... at an awards dinner benefiting the American Heart Association on ... , , The ...
... Electrical Infrastructure at VA Medical Center , ... one of the nation,s premier providers of full lifecycle services ... selected by the United States Army Corps of Engineers to ... the Veterans Affairs Medical Center (VAMC) in Atlanta, Georgia. , ...
... , ROCKVILLE, Md., Dec. 16 Some ... are likely to die in alcohol-related traffic crashes on New Year,s ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081216/NE52502 ) , ... recent analysis of National Highway Traffic Safety Administration statistics shows that, ...
... Diagnostics, Automated Immunoassay Analyzers , , ... Inc. and Roche Diagnostics announced today a worldwide license and ... agreement, Roche will develop an assay kit utilizing Fujirebio Diagnostics, ... , The HE4 test was developed by ...
... 16 Allscripts today announced that,the company,s Enterprise (formerly ... product in its market segment for the second year ... In its closely watched 2008,Top 20 Best in KLAS ... Care Management as the "Category Leader" in the,Discharge Planning ...
Cached Medicine News:Health News:New Easter Seals-MassMutual Study: Autism Strains Family Finances, Threatens Long-Term Care and Security 2Health News:New Easter Seals-MassMutual Study: Autism Strains Family Finances, Threatens Long-Term Care and Security 3Health News:Finalists Announced for American Heart Association's Paul 'Bear' Bryant College Football Coach of the Year Award 2Health News:Finalists Announced for American Heart Association's Paul 'Bear' Bryant College Football Coach of the Year Award 3Health News:Finalists Announced for American Heart Association's Paul 'Bear' Bryant College Football Coach of the Year Award 4Health News:M.C. Dean, Inc. Awarded Contract for Electrical Services at Atlanta VA Medical Center 2Health News:New Year, Old Myths, New Fatalities 2Health News:New Year, Old Myths, New Fatalities 3Health News:Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test 2Health News:Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test 3Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 3Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 4
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
The most advanced retinal cameras for fluorescein, color and ICG angiography with full digital imaging capability....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
All welded construction for strength and durability. Choice of stainless steel or chrome plated models....
Medicine Products: